Consequently, attempts to restore the IFN-γ production of T cells or the therapeutic administration of recombinant IFN-γ during sepsis harbor the risk to aggravate the dysregulation of DCs and presumably other immune cells through long-lasting modulation of the BM microenvironment (63). Here, IFNG is linked to Sepsis.